arrow
H

Hannah Bower

karolinska institutet
H指数:19
被引数:2,181

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Letter to the Editor Regarding “Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases”

致编辑函:关于“比较巴瑞替尼与TNFi治疗类风湿关节炎患者中VTE、MACE和严重感染的多数据库常规护理患者研究(利用疾病登记和理赔数据库)”

2025-09-260
OA
Do newly approved drugs have a worse observed safety profile than once established? A study on time trends in risks of key safety outcomes with immunomodulatory drugs against rheumatoid arthritis

新批准的药物是否比已建立的药物具有更差的观察性安全特征?一项关于治疗类风湿关节炎的免疫调节药物关键安全性结局风险的时间趋势研究

2025-02-010
OAAI